Literature DB >> 33194043

Porcine slaughterhouse lungs for ex vivo lung perfusion - a pilot project.

Katharina Kalka1, Zoe Keldenich1, Henning Carstens1, Gero Hilken2, Carolin Olbertz1, Nikolaus Pizanis1, Markus Kamler1, Gerald Reiner3, Achim Koch1.   

Abstract

Ex vivo lung perfusion (EVLP) is an emerging technique for evaluation and eventual reconditioning of donor lungs. Before clinical use experiments with laboratory animals are standard. It was the aim of this study to compare lungs evaluated with EVLP from laboratory animals with slaughterhouse lungs and to investigate the potential use of a slaughterhouse lung model for ex vivo lung perfusion as an alternative for the use of laboratory animals. In a porcine model of Donation after Circulatory Determination of Death (DCDD) 16 lungs were obtained either from regular slaughterhouse animals (SL n = 8) or from laboratory animals in organ procurements (SS n = 8). Lungs were flushed and stored cold for four hours in Perfadex Plus™ and subsequently perfused ex vivo with Steen Solution™ for up to four hours. During 4 hours of EVLP lung functional parameters and activities of lactate, lactate dehydrogenase (LDH) and alkaline phosphatase (AP) in the perfusate were recorded hourly. Histological samples were taken and evaluated fur Lung Injury. Lungs showed no significant difference in oxygen capacity in between groups (∆ PO2 averaged over 4 hours: SL 293 ± 187 mmHg SS 247 ± 199 mmHg). LDH concentration was significantly higher in slaughterhouse lungs (SL 438,5 ± 139,8 U/l, SS 258,42 ± 108,4 U/l P ≤ 0,01). We conclude that the use of slaughterhouse lungs for EVLP was feasible with no significant disadvantages compared to standard organ procurement lungs regarding lung functional outcomes. With the use of slaughterhouse lungs animal experiments in EVLP research could be successfully reduced. AJTR
Copyright © 2020.

Entities:  

Keywords:  EVLP; Lung transplantation; Steen Solution; organ harvesting; pig; slaughterhouse

Year:  2020        PMID: 33194043      PMCID: PMC7653587     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  18 in total

Review 1.  Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation.

Authors:  M Drent; N A Cobben; R F Henderson; E F Wouters; M van Dieijen-Visser
Journal:  Eur Respir J       Date:  1996-08       Impact factor: 16.671

Review 2.  Ex vivo lung perfusion prior to transplantation: an overview of current clinical practice worldwide.

Authors:  Julien Possoz; Arne Neyrinck; Dirk Van Raemdonck
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

Review 3.  Animal models of ex vivo lung perfusion as a platform for transplantation research.

Authors:  Kevin Nelson; Christopher Bobba; Samir Ghadiali; Don Hayes; Sylvester M Black; Bryan A Whitson
Journal:  World J Exp Med       Date:  2014-05-20

4.  Airway pressure release ventilation during ex vivo lung perfusion attenuates injury.

Authors:  J Hunter Mehaffey; Eric J Charles; Ashish K Sharma; Dustin T Money; Yunge Zhao; Mark H Stoler; Christine L Lau; Curtis G Tribble; Victor E Laubach; Mark E Roeser; Irving L Kron
Journal:  J Thorac Cardiovasc Surg       Date:  2016-09-22       Impact factor: 5.209

5.  Use of modified Custodiol-N as perfusion solution in ex vivo lung perfusion.

Authors:  Carolin Olbertz; Nikolaus Pizanis; Hagen Bäumker; Katharina Kalka; Clemens Aigner; Ursula Rauen; Ingo Nolte; Markus Kamler; Achim Koch
Journal:  Am J Transl Res       Date:  2020-01-15       Impact factor: 4.060

6.  Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo.

Authors:  Stig Steen; Qiuming Liao; Per N Wierup; Ramunas Bolys; Leif Pierre; Trygve Sjöberg
Journal:  Ann Thorac Surg       Date:  2003-07       Impact factor: 4.330

7.  Effect of complement inhibition with soluble complement receptor 1 on pig allotransplant lung function.

Authors:  A F Pierre; A M Xavier; M Liu; S D Cassivi; T F Lindsay; H C Marsh; A S Slutsky; S H Keshavjee
Journal:  Transplantation       Date:  1998-09-27       Impact factor: 4.939

8.  Effects of immediate versus delayed ex-vivo lung perfusion in a porcine cardiac arrest donation model.

Authors:  Carolin Olbertz; Nikolaus Pizanis; Hagen Bäumker; Simon Becker; Clemens Aigner; Ursula Rauen; Ingo Nolte; Markus Kamler; Achim Koch
Journal:  Int J Artif Organs       Date:  2019-07       Impact factor: 1.595

9.  Evaluation and reconditioning of donor organs for transplantation through ex vivo lung perfusion.

Authors:  Luis Gustavo Abdalla; Karina Andrighetti de Oliveira-Braga; Lucas Matos Fernandes; Marcos Naoyuki Samano; Paula Refinetti Camerini; Paulo Manuel Pêgo-Fernandes
Journal:  Einstein (Sao Paulo)       Date:  2019-07-15

10.  Immunoregulatory effects of multipotent adult progenitor cells in a porcine ex vivo lung perfusion model.

Authors:  An Martens; Sofie Ordies; Bart M Vanaudenaerde; Stijn E Verleden; Robin Vos; Dirk E Van Raemdonck; Geert M Verleden; Valerie D Roobrouck; Sandra Claes; Dominique Schols; Eric Verbeken; Catherine M Verfaillie; Arne P Neyrinck
Journal:  Stem Cell Res Ther       Date:  2017-07-05       Impact factor: 6.832

View more
  1 in total

Review 1.  Ex Vivo Lung Perfusion: A Review of Current and Future Application in Lung Transplantation.

Authors:  Kareem Ahmad; Jennifer L Pluhacek; A Whitney Brown
Journal:  Pulm Ther       Date:  2022-03-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.